Tandem Diabetes Care Inc (TNDM) — Cash Flow Reinvestment Rate
Tandem Diabetes Care Inc (TNDM) has a Cash Flow Reinvestment Rate of 17.68x as of March 2026, reinvesting $195.45 Million (capex $6.27 Million plus investments $-189.18 Million) from operating cash flow of $11.05 Million. Check cash flow quality index of Tandem Diabetes Care Inc to evaluate the quality of earnings relative to operating cash generation.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Tandem Diabetes Care Inc Cash Flow Reinvestment Rate (2019–2024)
Historical reinvestment intensity for Tandem Diabetes Care Inc across 5 annual periods. Explore Tandem Diabetes Care Inc long-term investment allocation to see how much of total assets are deployed in long-term investments.
Annual Cash Flow Reinvestment Rate for Tandem Diabetes Care Inc (2019–2024)
Year-by-year capital reinvestment analysis for Tandem Diabetes Care Inc. For live market cap and broader valuation context, see TNDM company net worth.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2024 | 1.76x | $42.71 Million | $24.23 Million | $19.23 Million | ▲ +32.3% |
| 2022 | 1.33x | $67.27 Million | $50.46 Million | $34.10 Million | ▼ -20.6% |
| 2021 | 1.68x | $186.88 Million | $111.36 Million | $23.51 Million | ▼ -86.0% |
| 2020 | 12.00x | $296.06 Million | $24.67 Million | $32.29 Million | ▲ +783.0% |
| 2019 | 1.36x | $56.95 Million | $41.91 Million | $19.54 Million | — |